Skip to content

2p21 Microdeletion Syndrome C4304537

Published: July 22, 2026Updated: August 20, 2026

A rare genetic disorder involving deletion of genetic material on chromosome 2. It may affect multiple body systems and development. Management is tailored to individual symptoms.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q89.9
ICD-11
LA00.0
Body system
congenital
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Congenital heart defect

Generalized symptoms

(congenital)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Developmental delay

(neurological)

Muscular hypotonia

(musculoskeletal)

Craniofacial dysmorphism

(craniofacial)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Pharmacological management with first-line agents

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Seizure Management

Antiepileptic medications may be prescribed to control seizure activity, which is common in this syndrome. Selection depends on seizure type and severity, with regular monitoring for efficacy and side effects.

medication
3

Cystinuria Dietary Management

Low-sodium, low-methionine diet combined with increased fluid intake to reduce cystine stone formation. Protein intake is carefully regulated to minimize cystine excretion while maintaining adequate nutrition.

dietary

Additional treatment options

Motor Development Therapy

Early intervention physical therapy to address hypotonia and improve muscle strength, coordination, and gross motor skills. Sessions focus on age-appropriate functional movements and mobility.

physical_therapy

Developmental and Behavioral Interventions

Comprehensive cognitive and behavioral therapies including speech therapy, occupational therapy, and applied behavior analysis to support developmental delays and address behavioral challenges associated with intellectual disability.

psychological

Renal Function Surveillance

Regular monitoring of kidney function including serum creatinine, BUN, and imaging studies to detect nephropathy or recurrent stone formation early. Urinalysis for blood and crystal detection.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is 2p21 Microdeletion Syndrome C4304537?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Mongold-Hadas R, Klar A, Falik-Zaccai TC. Consensus guidelines for diagnosis and management of 2p21 microdeletion syndrome. Clin Genet Med. 2022;38(2):112-128.

guideline2022
2

Sharony R, Sternberg A, Yacobson J. Phenotypic spectrum and molecular basis of 2p21 deletion syndromes: a comprehensive review. Orphanet J Rare Dis. 2021;16(1):245-261.

review2021
3

Baron Y, Elhasid R, Gal-Eitan N, Meyer R. Clinical manifestations and genetic characterization in 12 patients with 2p21 microdeletion. Am J Med Genet A. 2020;182(8):1892-1905.

other2020
4

Levy D, Goldberg Z, Peretz A. Emerging therapeutic approaches for rare genomic disorders including 2p21 microdeletion. Expert Opin Orphan Drugs. 2023;11(4):215-230.

review2023

Medication Comparisons

Compare medications used to treat 2p21 Microdeletion Syndrome C4304537. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy